Navigation Links
Perioperative chemoradiotherapy in esophageal squamous cell carcinoma
Date:4/9/2010

Esophagectomy is a standard treatment for resectable esophageal carcinoma but relatively few patients are cured. Combined neoadjuvant chemoradiotherapy (CRT) or adjuvant CRT with surgery may improve survival but there is concern about treatment morbidity and the best sequencing of CRT and surgery.

A research team from China used a prospective study, based on randomized controlled trial design, to compare preoperative and postoperative CRT to surgery alone in patients with resectable esophageal squamous cell carcinoma (ESCC). Their study will be published on April 7, 2010 in the World Journal of Gastroenterology.

With median follow-up of 45 mo for all the enrolled patients, significant differences in the 1-, 3-, 5-, 10-year overall survival (OS) and progression-free survival (PFS) were detected among the the preoperative CRT, postoperative CRT and surgery groups, respectively. There were no significant differences in OS and PFS between the preoperative CRT and postoperative CRT arm. For the patients who had radical resection, significant differences in median PFS and median OS were detected among the 3 arms, but there were no significant differences in OS and PFS between the preoperative CRT and postoperative CRT arm. The local recurrence rates in the preoperative CRT, postoperative CRT group and S group were 11.3%, 14.1% and 35%, respectively. No significant differences were detected among the 3 groups when comparing complications but tended to be in favor of the postoperative CRT and S groups. Toxicities of CRT in the preoperative or postoperative CRT arms were mostly moderate, and could be quickly alleviated by adequate therapy.

Their results illustrated that long-term survival is maximized by the use of CRT followed by surgery for locally advanced esophageal cancer. However, patients are more likely to develop toxicity. As therapies improve, it is likely that the toxicity may be reduced and neoadjuvant CRT may provide a mor
'/>"/>

Contact: Ye-Ru Wang
wjg@wjgnet.com
86-105-908-0039
World Journal of Gastroenterology
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Patients with resectable esophageal adenocarcinoma benefit from neoadjuvant chemoradiotherapy
2. February Fundraiser Launches Cohen Esophageal Cancer Initiative (CECI)
3. Why does percutaneous endoscopic gastrostomy fail to eliminate gastroesophageal reflux?
4. Alzheimers Drug Might Help Prevent Esophageal Cancer
5. Prognosis of intrahepatic cholangiocarcinoma
6. News brief: ALDH associated with worse overall survival in patients with pancreatic adenocarcinoma
7. Different signaling pathways of cholangiocarcinoma
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/3/2015)... Johnson & Johnson and its Janssen Pharmaceuticals ... a Risperdal lawsuit ( http://www.risperdallawsuit2014.com/ ) filed by the ... to market the antipsychotic drug. Court records filed ... Attorney General moved to dismiss the case on May ... amounts to just a fraction of the $1.2 billion ...
(Date:6/3/2015)... The National Resident Matching Program Board ... M.D., Dean of Medical Education at the University of California, ... July 1. , “It is an honor to ... Program,” said Dr. Savoia. “NRMP’s goal is to provide ... with training programs, and I welcome the opportunity to guide ...
(Date:6/3/2015)... On the heels of a report predicting ... 2020 ( click here to review news coverage about ... Baltimore has the talent to become a world-leading center ... and other biological data are collected and analyzed to help ... all the elements of a perfect storm for bioinformatics leadership,” ...
(Date:6/3/2015)... Horizon Blue Cross Blue Shield of New Jersey has ... nation’s top employers for diverse managers and women. The ... of Best Places for Diverse Managers and Women to Work ... This is the sixth consecutive year that Horizon BCBSNJ ... workplace policies and programs. , Companies are selected based on ...
(Date:6/3/2015)... June 03, 2015 VeoMed and ... expand online and mobile access to premier Continuing ... Maintenance of Certification (MOC) activities. ... innovative courses to Decker’s extensive lists of physicians, ... purchasing access to VeoMed’s premier online and live-streamed ...
Breaking Medicine News(10 mins):Health News:Risperdal Lawsuit News: Johnson & Johnson, Janssen Settle Arkansas Marketing Case for $7.8 Million 2Health News:Risperdal Lawsuit News: Johnson & Johnson, Janssen Settle Arkansas Marketing Case for $7.8 Million 3Health News:Risperdal Lawsuit News: Johnson & Johnson, Janssen Settle Arkansas Marketing Case for $7.8 Million 4Health News:NRMP Board of Directors Elects New Leadership and Members at its May 2015 Meeting 2Health News:NRMP Board of Directors Elects New Leadership and Members at its May 2015 Meeting 3Health News:NRMP Board of Directors Elects New Leadership and Members at its May 2015 Meeting 4Health News:Baltimore Poised to Become a World-Leading Hub of Multi-Billion Dollar Bioinformatics Industry 2Health News:Baltimore Poised to Become a World-Leading Hub of Multi-Billion Dollar Bioinformatics Industry 3Health News:Horizon Blue Cross Blue Shield of New Jersey Named a 2015 Best Place for Diverse Managers and Women to Work by Diversity MBA Magazine 2Health News:VeoMed and Decker Intellectual Properties, the Owner of Scientific American Medicine, Announce a Partnership to Expand Access to Premier Online CME Courses 2
... The way locusts react to stress may provide ... and how to reduce their painful effects, says ... student Corinne Rodgers, Dr. Robertson is using insect models ... stress is induced through high temperatures and oxygen deprivation. ...
... success of the first three years of the American ... Physicians Foundation (ACPF) Diabetes Initiative, the program has received ... initiative for an additional two years through December 2009. ... our efforts confirm that optimal diabetes care requires a ...
... Capital Management, the,owner, together with its affiliates, of nearly ... Inc. (Nasdaq: VSTA ), announced today,that it had ... belief that the offer by Odyssey Healthcare, Inc. (Nasdaq: ... is wholly inadequate. Accipiter,Capital Management and its affiliates do ...
... Merit Medical,Systems, Inc. (Nasdaq: MMSI ), a ... in cardiology and radiology,procedures, announced today that the Company ... year ended December 31, 2007, after the,close of the ... will hold its investor conference call on the same ...
... Lotus Pharmaceuticals,Inc. (OTC Bulletin Board: LTUS) ("Lotus" ... People,s Republic of China ("PRC"), today,announced that ... owned,subsidiary of Lotus, has implemented cost saving ... costs by approximately 50%., The environmentally-friendly ...
... Hybrid electric vehicles that run on both conventional ... than a stop gap until more sustainable technology ... in the Inderscience publication International Journal of Automotive ... of HEVs might even slow development of more ...
Cached Medicine News:Health News:Comatose locusts may help relieve migraines 2Health News:Team-based approach improves diabetes care 2Health News:Team-based approach improves diabetes care 3Health News:Accipiter Capital Management Opposes Acquisition of VistaCare, Inc. by Odyssey Healthcare, Inc. 2Health News:Accipiter Capital Management Opposes Acquisition of VistaCare, Inc. by Odyssey Healthcare, Inc. 3Health News:Accipiter Capital Management Opposes Acquisition of VistaCare, Inc. by Odyssey Healthcare, Inc. 4Health News:Accipiter Capital Management Opposes Acquisition of VistaCare, Inc. by Odyssey Healthcare, Inc. 5Health News:Accipiter Capital Management Opposes Acquisition of VistaCare, Inc. by Odyssey Healthcare, Inc. 6Health News:Merit Medical Systems Announces Earnings Release Date/Time and Conference Call Information for the Year Ended December 31, 2007 2Health News:Merit Medical Systems Announces Earnings Release Date/Time and Conference Call Information for the Year Ended December 31, 2007 3Health News:Lotus Pharmaceuticals, Inc. Implements Environmentally-friendly Cost Saving Strategies 2Health News:The trouble with hybrids 2
(Date:6/3/2015)... , June 02, 2015 Research and ... of the "Global Neurodegenerative Diseases Market 2015-2019" ... global neurodegenerative diseases market to grow at a ... This report covers the present scenario and ... market for the period 2015-2019. To calculate the ...
(Date:6/3/2015)... PillPack, the pharmacy that simplifies medication management, today announced ... led by CRV with participation from Accel Partners, Atlas ... be used to fuel growth, accelerate the hiring of ... markets. "In the last two years, we,ve ... folks absolutely love," says TJ Parker, PharmD, CEO of ...
(Date:6/3/2015)... Calif. , June 3, 2015  Armetheon, ... molecule drugs for cardiovascular diseases, today announced that ... been appointed Chief Executive Officer, effective immediately. Dr. ... in global, high-growth enterprises, with a successful track ... of human health. With expertise that includes the ...
Breaking Medicine Technology:Global Neurodegenerative Diseases Market 2015-2019 - Reformulation of Marketed Drugs 2PillPack Raises $50 Million to Build Retail Footprint and Accelerate Growth 2PillPack Raises $50 Million to Build Retail Footprint and Accelerate Growth 3Armetheon Names Dr. Sanjay Kakkar as Chief Executive Officer 2Armetheon Names Dr. Sanjay Kakkar as Chief Executive Officer 3Armetheon Names Dr. Sanjay Kakkar as Chief Executive Officer 4
... Flextend lead is a ... with an extendable/retractable active-fixation ... design offers various lead ... implantation in the atrium ...
... leads are implantable bipolar extendable/retractable screw-in ... either the atrium or the ventricle. ... be extended or retracted by turning ... contains an anti-chattering mechanism for steady ...
Used with permanent pacing leads....
... Tupos LA, the only ICD system in ... the first implant for the treatment of ... a lasting improvement of their hemodynamics and ... LA uses biatrial stimulation to effectively suppress ...
Medicine Products: